The core principle involves identifying specific lysosomal storage diseases based on the enzymatic deficiency that prevents the hydrolysis of distinct macromolecular substrates within cells. This mechanism dictates cellular pathology through the selective accumulation of abnormal materials, such as sphingomyelin in Niemann-Pick disease or GM2 ganglioside in Tay-Sachs disease, distinguishing conditions by clinical markers like hepatosplenomegaly and cherry-red spots. Theoretical differentiation relies on mapping enzyme names to their corresponding accumulated substrates while accounting for inheritance patterns (e.g., X-linked vs. autosomal) that define the genetic scope of each disorder within metabolic pathology.
The core principle involves identifying specific lysosomal storage diseases based on the enzymatic deficiency that prevents the hydrolysis of distinct macromolecular substrates within cells. This mec…